Zai Lab Ltd. (ZLAB)
23.52
-1.08
(-4.39%)
USD |
NASDAQ |
Nov 16, 16:00
23.52
0.00 (0.00%)
After-Hours: 20:00
Zai Lab Enterprise Value : 2.374B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.374B |
| November 12, 2026 | 2.536B |
| November 11, 2026 | 2.578B |
| November 10, 2026 | 2.579B |
| November 09, 2026 | 2.628B |
| November 06, 2026 | 2.473B |
| November 05, 2026 | 2.149B |
| November 04, 2026 | 2.171B |
| November 03, 2026 | 2.077B |
| November 02, 2026 | 2.044B |
| October 30, 2026 | 2.089B |
| October 29, 2026 | 2.122B |
| October 28, 2026 | 2.198B |
| October 27, 2026 | 2.259B |
| October 26, 2026 | 2.344B |
| October 23, 2026 | 2.310B |
| October 22, 2026 | 2.086B |
| October 21, 2026 | 2.329B |
| October 20, 2026 | 2.428B |
| October 19, 2026 | 2.313B |
| October 16, 2026 | 2.215B |
| October 15, 2026 | 2.251B |
| October 14, 2026 | 2.138B |
| October 13, 2026 | 2.205B |
| October 12, 2026 | 2.373B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.417B |
| October 08, 2026 | 2.397B |
| October 07, 2026 | 2.453B |
| October 06, 2026 | 2.484B |
| October 05, 2026 | 2.488B |
| October 02, 2026 | 2.343B |
| October 01, 2026 | 2.475B |
| September 30, 2026 | 2.569B |
| September 29, 2026 | 2.448B |
| September 28, 2026 | 2.421B |
| September 25, 2026 | 2.341B |
| September 24, 2026 | 2.375B |
| September 23, 2026 | 2.505B |
| September 22, 2026 | 2.501B |
| September 21, 2026 | 2.504B |
| September 18, 2026 | 2.422B |
| September 17, 2026 | 2.434B |
| September 16, 2026 | 2.306B |
| September 15, 2026 | 2.321B |
| September 14, 2026 | 2.296B |
| September 11, 2026 | 2.247B |
| September 10, 2026 | 2.250B |
| September 09, 2026 | 2.352B |
| September 08, 2026 | 2.389B |
| September 04, 2026 | 2.481B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Kintor Pharmaceutical Ltd. | -- |
| Jacobio Pharmaceuticals Group Co., Ltd. | -- |
| Adlai Nortye Group Ltd. | 595.28M |
| Moderna, Inc. | 89.30B |
| Oncolytics Biotech, Inc. | 46.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -46.26M |
| Revenue (Quarterly) | 108.50M |
| Total Expenses (Quarterly) | 154.76M |
| EPS Diluted (Quarterly) | -0.4118 |
| Gross Profit Margin (Quarterly) | 52.59% |
| Profit Margin (Quarterly) | -42.64% |
| Earnings Yield | -7.60% |
| Normalized Earnings Yield | -7.600 |